Mylomid Capsule 10 mg contains Lenalidomide, a potent immunomodulatory and antineoplastic agent used in the treatment of various blood-related cancers. Lenalidomide is a derivative of thalidomide, designed to enhance the body’s immune response while inhibiting the growth of malignant cells. Its unique mechanism combines anti-inflammatory, anti-angiogenic, and cytotoxic effects, making it highly effective in managing multiple myeloma and other hematologic disorders.
Lenalidomide works by modulating the immune system to enhance T-cell and natural killer (NK) cell activity, promoting the destruction of abnormal cells. It also interferes with cytokine production and inhibits the formation of new blood vessels that supply tumors, thereby slowing cancer progression. Mylomid Capsule 10 mg provides targeted therapy that improves patient outcomes when used under strict medical supervision.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Mylomid Capsule 10 mg is indicated for:
Multiple myeloma, either newly diagnosed or relapsed/refractory, often in combination with other agents such as dexamethasone
Myelodysplastic syndromes (MDS) associated with deletion 5q chromosomal abnormality
Certain types of mantle cell lymphoma (as directed by a hematologist)
Other hematologic malignancies as recommended by an oncologist
The capsule is generally used as part of combination therapy under a structured treatment plan to maximize efficacy and reduce disease progression.
Targets abnormal blood cells while enhancing immune function
Inhibits tumor growth by blocking angiogenesis
Reduces progression and recurrence of multiple myeloma and MDS
Improves patient outcomes when used with other chemotherapeutic or supportive agents
Provides oral administration for convenient outpatient therapy
Lenalidomide’s multifaceted mechanism makes Mylomid Capsule 10 mg an essential component of modern hematology treatment protocols.
Dosage varies depending on the condition, treatment phase, and patient response; it should always be determined by a registered hematologist or oncologist.
Capsules should be taken once daily, at the same time each day, with or without food.
Swallow capsules whole; do not crush, chew, or open them.
Regular blood tests and monitoring are required to assess blood counts, kidney function, and treatment response.
Patients must adhere strictly to the prescribed regimen to avoid serious complications.
Strictly avoid pregnancy during treatment; Lenalidomide can cause severe birth defects. Both male and female patients should follow contraception guidelines.
Use under supervision in patients with kidney or liver impairment.
Monitor for blood clots, infections, or significant changes in blood counts.
Inform your doctor of all medications being taken to prevent drug interactions.
Avoid live vaccines during therapy.
While Mylomid Capsule 10 mg is effective, some patients may experience:
Fatigue or weakness
Low blood counts (anemia, neutropenia, thrombocytopenia)
Constipation, diarrhea, or nausea
Skin rash or itching
Risk of blood clots or infections
Regular medical follow-up is essential to detect and manage adverse effects promptly.
Store below 30°C in a dry place, protected from light and moisture. Keep out of reach of children and ensure capsules are stored in the original packaging.
Mylomid Capsule 10 mg (Lenalidomide) is a specialized therapy for hematologic malignancies, offering immunomodulatory and antineoplastic benefits that help control disease progression and improve patient outcomes under careful medical supervision.
Login Or Registerto submit your questions to seller
No none asked to seller yet